Does Treatment of Erectile Dysfunction With PDE 5 Inhibitor Tadalafil Improve Quality of Life in Male Patients With Compensated Chronic Liver Disease? A Prospective Pilot Study.
作者:
关键词
ALD, alcoholic liver diseaseCLD, chronic liver diseaseED, Erectile dysfunctionFIB-4FIB-4, fibrosis index based on 4 factorsHRQOL, health-related quality of lifeIIEF-5IIEF-5, the International Index of Erectile Function-5LC, liver cirrhosisLSM, liver stiffness measurementMAP, mean arterial pressurePDE-5 IPDE5-I, phosphodiesterase inhibitorsPDEs, phosphodiesterasesPPH, porto-pulmonary hypertensionQOL, quality of lifeSMT, standard medical therapyTAA, thioacetamideTE, transient elastographyWHOQOL-BREFcAMP, cyclic adenosine monophosphatecGMP, cyclic guanosine monophosphateerectile dysfunction
DOI
10.1016/j.jceh.2022.01.009
PMID
35814506
发布时间
2023-07-03
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文